|
|
Preparation of probes for the cancer imaging based on single photon emission computer tomography (SPECT) based on peptidomimetic inhibitors of FAP protease
Trajhan, Filip ; Konvalinka, Jan (advisor) ; Baszczyňski, Ondřej (referee)
Fibroblast activation protein (FAP) is a membrane serine protease that is mainly expressed in epithelial tumor cells. The specific occurrence in the tumor microenvironment and its absence in most healthy tissues makes this protein an important target for the development of diagnostic probes or targeted endoradiotherapy. The goal of this work is the preparation of a new series of potential probes for SPECT imaging of tumours using low molecular weight FAP inhibitors. The structure and synthetic strategy for four new probes were proposed. At the same time two already published probes serving as references for biodistribution experiments were prepared. Two probes were based on the compound IOCB22-AP446, the most potent FAP inhibitor published so far, which was developed in the laboratory of prof. Konvalinka at the IOCB, Prague. The other four prepared probes used the inhibitor UAMC1110, which is utilized as a targeting molecule in a number of compounds in the clinical testing phase. The degree of FAP inhibition in vitro was determined for all prepared compounds. Furthermore, the ability of the probes to visualise tumour tissue in vivo was tested on two animal models of human tumours. Comparison of the results with published data led to the validation of one of the models for use in further...
|
|
|
Definition of the expression pattern of DASH system in transformed glial cells, the coupled expression of fibroblast activation protein and dipeptidyl peptidase-IV.
Balážiová, Eva ; Šedo, Aleksi (advisor) ; Borovanský, Jan (referee) ; Mareš, Vladislav (referee)
Dipeptidyl peptidase-IV (DPP-IV) is a multifunctional transmembrane glycoprotein removing X-Pro dipeptide from the amino-terminus of the peptide chain. This evolutionary conserved sequence protects a number of biologically active peptides against the unspecific proteolytic cleavage. DPP-IV belongs into the group of "Dipeptidyl peptidase-IV Activity and/or Structure Homologues" (DASH), which, except the canonical DPP-IV, comprises fibroblast activation protein-α/seprase (FAP), and several other molecules. However several of DASH molecules are the enzymes, they execute at least some of their biological functions by non-proteolytic protein-protein interactions. DASH molecules, their substrates and binding partners are parts of "DASH system" which is affected in several pathological process including a cancer. Specifically DPP-IV and its closest structural relative FAP are among others expected to be involved in the development and progression of malignant glioma. In this study we showed the expression and colocalization of DPP-IV and FAP in glioma cells in vitro and in human high grade gliomas. In addition to the DPP-IV/FAP double positive transformed glial cells, we also identified a subpopulation of FAP positive mesenchymal cells located in the perivascular compartment. Moreover we described the...
|
|
|
Dipeptidyl peptidase-IV and Fibroblast activation protein in gliomagenesis.
Trylčová, Jana ; Šedo, Aleksi (advisor) ; Mandys, Václav (referee) ; Mareš, Vladislav (referee)
"Dipeptidyl peptidase-IV Activity and/or Structure Homologues"(DASH) represent a newly defined group of multifunctional molecules, typically bearing dipeptidyl peptidase-IV- like hydrolytic activity. Dipeptidyl peptidase-IV (DPP-IV) cleaves out X-Pro dipeptides from the N-terminus of peptides. Other molecules carrying similar enzyme activity, such as Fibroblast activation protein (FAP), DPP-II, DPP8 and DPP9 or even DPP-IV structure-like but hydrolytically inactive molecules (DPP6 and DPP10) also belong to this group. Recent knowledge suggest a substantial role of DASH in cancer pathogenesis. The aim of this study is a preparation of a biological model and its use for understanding the mechanisms of interaction(s) between transformed glial cells and stroma in the processes of origin and development of tumors derived from neuroectoderm. Stable transfected human glioblastoma cell lines with inducible gene expression of DPP-IV, Fibroblast activation protein and their enzymatically inactive mutated forms, were prepared within the project. Prepared cell lines are used as a tool for studying not only the "autocrine" importance of DPP-IV and FAP for the expressing cells in in-vitro, but also for their potential "paracrine" effect(s) within the tumor microenvironment after homotopic implantation into the...
|
|
|
Definition of the expression pattern of DASH system in transformed glial cells, the coupled expression of fibroblast activation protein and dipeptidyl peptidase-IV.
Balážiová, Eva ; Šedo, Aleksi (advisor) ; Borovanský, Jan (referee) ; Mareš, Vladislav (referee)
Dipeptidyl peptidase-IV (DPP-IV) is a multifunctional transmembrane glycoprotein removing X-Pro dipeptide from the amino-terminus of the peptide chain. This evolutionary conserved sequence protects a number of biologically active peptides against the unspecific proteolytic cleavage. DPP-IV belongs into the group of "Dipeptidyl peptidase-IV Activity and/or Structure Homologues" (DASH), which, except the canonical DPP-IV, comprises fibroblast activation protein-α/seprase (FAP), and several other molecules. However several of DASH molecules are the enzymes, they execute at least some of their biological functions by non-proteolytic protein-protein interactions. DASH molecules, their substrates and binding partners are parts of "DASH system" which is affected in several pathological process including a cancer. Specifically DPP-IV and its closest structural relative FAP are among others expected to be involved in the development and progression of malignant glioma. In this study we showed the expression and colocalization of DPP-IV and FAP in glioma cells in vitro and in human high grade gliomas. In addition to the DPP-IV/FAP double positive transformed glial cells, we also identified a subpopulation of FAP positive mesenchymal cells located in the perivascular compartment. Moreover we described the...
|
guest ::
